Eli Lily reduces German investments by half

American company Eli Lilly has decided to cut its investments in a new manufacturing facility in Germany by 50%. The company had planned to invest $2.5 billion in the German city of Altsey. This decision came as a result of the German government's measures to reduce healthcare spending, particularly the "Contribution Rate Stabilization Plan" for mandatory health insurance. As a result, Germany's support for the pharmaceutical industry in European markets has declined.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل